BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26227398)

  • 41. Regulation of adipogenesis through retinoid X receptor and/or peroxisome proliferator-activated receptor by designed lignans based on natural products in 3T3-L1 cells.
    Nakashima KI; Okamura M; Matsumoto I; Kameda N; Tsuboi T; Yamaguchi E; Itoh A; Inoue M
    J Nat Med; 2023 Mar; 77(2):315-326. PubMed ID: 36607539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rosiglitazone induction of Insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein in the regulation of adipogenesis.
    Kast-Woelbern HR; Dana SL; Cesario RM; Sun L; de Grandpre LY; Brooks ME; Osburn DL; Reifel-Miller A; Klausing K; Leibowitz MD
    J Biol Chem; 2004 Jun; 279(23):23908-15. PubMed ID: 15073165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness.
    Yao-Borengasser A; Rassouli N; Varma V; Bodles AM; Rasouli N; Unal R; Phanavanh B; Ranganathan G; McGehee RE; Kern PA
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4431-9. PubMed ID: 18697866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Poly(ADP-ribose) polymerase-2 [corrected] controls adipocyte differentiation and adipose tissue function through the regulation of the activity of the retinoid X receptor/peroxisome proliferator-activated receptor-gamma [corrected] heterodimer.
    Bai P; Houten SM; Huber A; Schreiber V; Watanabe M; Kiss B; de Murcia G; Auwerx J; Ménissier-de Murcia J
    J Biol Chem; 2007 Dec; 282(52):37738-46. PubMed ID: 17951580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Peroxisome Proliferator-Activated Receptor (PPAR)-
    Schubert M; Becher S; Wallert M; Maeß MB; Abhari M; Rennert K; Mosig AS; Große S; Heller R; Grün M; Lorkowski S
    Mol Pharmacol; 2020 Mar; 97(3):212-225. PubMed ID: 31871304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved insulin sensitivity after treatment with PPARγ and PPARα ligands is mediated by genetically modulated transcripts.
    Rasouli N; Kern PA; Elbein SC; Sharma NK; Das SK
    Pharmacogenet Genomics; 2012 Jul; 22(7):484-97. PubMed ID: 22437669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cinnamaldehyde potentially attenuates gestational hyperglycemia in rats through modulation of PPARγ, proinflammatory cytokines and oxidative stress.
    Hosni AA; Abdel-Moneim AA; Abdel-Reheim ES; Mohamed SM; Helmy H
    Biomed Pharmacother; 2017 Apr; 88():52-60. PubMed ID: 28092845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retinoic acid treatment increases lipid oxidation capacity in skeletal muscle of mice.
    Amengual J; Ribot J; Bonet ML; Palou A
    Obesity (Silver Spring); 2008 Mar; 16(3):585-91. PubMed ID: 18239600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Porcine peroxisome proliferator-activated receptor delta mediates the lipolytic effects of dietary fish oil to reduce body fat deposition.
    Yu YH; Wang PH; Cheng WT; Mersmann HJ; Wu SC; Ding ST
    J Anim Sci; 2010 Jun; 88(6):2009-18. PubMed ID: 20190170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor γ-sparing thiazolidinedione.
    Chen Z; Vigueira PA; Chambers KT; Hall AM; Mitra MS; Qi N; McDonald WG; Colca JR; Kletzien RF; Finck BN
    J Biol Chem; 2012 Jul; 287(28):23537-48. PubMed ID: 22621923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.
    Schoonjans K; Peinado-Onsurbe J; Lefebvre AM; Heyman RA; Briggs M; Deeb S; Staels B; Auwerx J
    EMBO J; 1996 Oct; 15(19):5336-48. PubMed ID: 8895578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A nonthiazolidinedione peroxisome proliferator-activated receptor α/γ dual agonist CG301360 alleviates insulin resistance and lipid dysregulation in db/db mice.
    Jeong HW; Lee JW; Kim WS; Choe SS; Shin HJ; Lee GY; Shin D; Lee JH; Choi EB; Lee HK; Yon GH; Cho B; Kim HR; Choi SH; Chung YS; Park SB; Chung H; Ro S; Kim JB
    Mol Pharmacol; 2010 Nov; 78(5):877-85. PubMed ID: 20724462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects.
    Berger J; Leibowitz MD; Doebber TW; Elbrecht A; Zhang B; Zhou G; Biswas C; Cullinan CA; Hayes NS; Li Y; Tanen M; Ventre J; Wu MS; Berger GD; Mosley R; Marquis R; Santini C; Sahoo SP; Tolman RL; Smith RG; Moller DE
    J Biol Chem; 1999 Mar; 274(10):6718-25. PubMed ID: 10037770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nuclear receptors regulate lipid metabolism and oxidative stress markers in chondrocytes.
    Ratneswaran A; Sun MM; Dupuis H; Sawyez C; Borradaile N; Beier F
    J Mol Med (Berl); 2017 Apr; 95(4):431-444. PubMed ID: 28070626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
    Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
    Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peroxisome proliferator-activated receptor-γ in capillary endothelia promotes fatty acid uptake by heart during long-term fasting.
    Goto K; Iso T; Hanaoka H; Yamaguchi A; Suga T; Hattori A; Irie Y; Shinagawa Y; Matsui H; Syamsunarno MR; Matsui M; Haque A; Arai M; Kunimoto F; Yokoyama T; Endo K; Gonzalez FJ; Kurabayashi M
    J Am Heart Assoc; 2013 Jan; 2(1):e004861. PubMed ID: 23525438
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene.
    Frohnert BI; Hui TY; Bernlohr DA
    J Biol Chem; 1999 Feb; 274(7):3970-7. PubMed ID: 9933587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart.
    Wang P; Liu J; Li Y; Wu S; Luo J; Yang H; Subbiah R; Chatham J; Zhelyabovska O; Yang Q
    Circ Res; 2010 Mar; 106(5):911-9. PubMed ID: 20075336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol.
    Floyd ZE; Wang ZQ; Kilroy G; Cefalu WT
    Metabolism; 2008 Jul; 57(7 Suppl 1):S32-8. PubMed ID: 18555852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
    Chen Y; Li Y; Wang Y; Wen Y; Sun C
    Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.